Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 3
1992 2
1993 1
1994 1
1995 1
1996 2
2001 1
2003 1
2004 3
2005 3
2006 5
2007 17
2008 11
2009 9
2010 14
2011 17
2012 14
2013 20
2014 10
2015 10
2016 14
2017 12
2018 15
2019 11
2020 7
2021 12
2022 15
2023 17
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial.
Boers M, Hartman L, Opris-Belinski D, Bos R, Kok MR, Da Silva JA, Griep EN, Klaasen R, Allaart CF, Baudoin P, Raterman HG, Szekanecz Z, Buttgereit F, Masaryk P, Klausch LT, Paolino S, Schilder AM, Lems WF, Cutolo M; GLORIA Trial consortium. Boers M, et al. Among authors: allaart cf. Ann Rheum Dis. 2022 Jul;81(7):925-936. doi: 10.1136/annrheumdis-2021-221957. Epub 2022 May 31. Ann Rheum Dis. 2022. PMID: 35641125 Free PMC article. Clinical Trial.
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial.
Krijbolder DI, Verstappen M, van Dijk BT, Dakkak YJ, Burgers LE, Boer AC, Park YJ, de Witt-Luth ME, Visser K, Kok MR, Molenaar ETH, de Jong PHP, Böhringer S, Huizinga TWJ, Allaart CF, Niemantsverdriet E, van der Helm-van Mil AHM. Krijbolder DI, et al. Among authors: allaart cf. Lancet. 2022 Jul 23;400(10348):283-294. doi: 10.1016/S0140-6736(22)01193-X. Lancet. 2022. PMID: 35871815 Clinical Trial.
Disease progression in systemic sclerosis.
van Leeuwen NM, Liem SIE, Maurits MP, Ninaber M, Marsan NA, Allaart CF, Huizinga TWJ, Knevel R, de Vries-Bouwstra JK. van Leeuwen NM, et al. Among authors: allaart cf. Rheumatology (Oxford). 2021 Mar 2;60(3):1565-1567. doi: 10.1093/rheumatology/keaa911. Rheumatology (Oxford). 2021. PMID: 33404661 Free PMC article. No abstract available.
What have we learned from BeSt?
Allaart CF, Markusse IM, Lems WF. Allaart CF, et al. Clin Immunol. 2018 Jan;186:74-78. doi: 10.1016/j.clim.2017.09.017. Epub 2017 Sep 18. Clin Immunol. 2018. PMID: 28927869 Free article. Clinical Trial.
IgG Anti-Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross-Sectional Study Encompassing ~1,500 Samples.
Kissel T, Hafkenscheid L, Wesemael TJ, Tamai M, Kawashiri SY, Kawakami A, El-Gabalawy HS, van Schaardenburg D, Rantapää-Dahlqvist S, Wuhrer M, van der Helm-van Mil AHM, Allaart CF, van der Woude D, Scherer HU, Toes REM, Huizinga TWJ. Kissel T, et al. Among authors: allaart cf. Arthritis Rheumatol. 2022 Jul;74(7):1147-1158. doi: 10.1002/art.42098. Epub 2022 May 28. Arthritis Rheumatol. 2022. PMID: 35188715 Free PMC article.
Drug-free remission: is it already possible?
van den Broek M, Huizinga TW, Dijkmans BA, Allaart CF. van den Broek M, et al. Among authors: allaart cf. Curr Opin Rheumatol. 2011 May;23(3):266-72. doi: 10.1097/BOR.0b013e32834563e3. Curr Opin Rheumatol. 2011. PMID: 21427578 Review.
The Leiden Early Arthritis Clinic.
van Aken J, van Bilsen JH, Allaart CF, Huizinga TW, Breedveld FC. van Aken J, et al. Among authors: allaart cf. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S100-5. Clin Exp Rheumatol. 2003. PMID: 14969059 Review.
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial.
Almayali AAH, Boers M, Hartman L, Opris D, Bos R, Kok MR, Da Silva JA, Griep E, Klaasen R, Allaart CF, Baudoin P, Raterman HG, Szekanecz Z, Buttgereit F, Masaryk P, Lems W, Smulders Y, Cutolo M, Ter Wee MM. Almayali AAH, et al. Among authors: allaart cf. Ann Rheum Dis. 2023 Oct;82(10):1307-1314. doi: 10.1136/ard-2023-223977. Epub 2023 Aug 4. Ann Rheum Dis. 2023. PMID: 37541762 Clinical Trial.
219 results